Wird geladen...

UPLC-MS based urine untargeted metabolomic analyses to differentiate bladder cancer from renal cell carcinoma

BACKGROUND: To discover biomarker panels that could distinguish cancers (BC and RCC) from healthy controls (HCs) and bladder cancers (BC) from renal cell carcinoma (RCC), regardless of whether the patients have haematuria. In addition, we also explored the altered metabolomic pathways of BC and RCC....

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:BMC Cancer
Hauptverfasser: Wang, Zhan, Liu, Xiaoyan, Liu, Xiang, Sun, Haidan, Guo, Zhengguang, Zheng, Guoyang, Zhang, Yushi, Sun, Wei
Format: Artigo
Sprache:Inglês
Veröffentlicht: BioMed Central 2019
Schlagworte:
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6896793/
https://ncbi.nlm.nih.gov/pubmed/31805976
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-019-6354-1
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!